News Amylyx Pharmaceuticals Reports the First Participant Dosing in P-III (LUCIDITY) Study Evaluating Avexitide in PBHByRidhi RastogiMay 1, 20250Comments
News Vertex Pharmaceuticals’ Alyftrek Receives the CHMP’s Positive Opinion for the Treatment of Cystic FibrosisByRidhi RastogiMay 1, 20250Comments
News Satsuma Pharmaceuticals’ Atzumi (Dihydroergotamine) Nasal Powder Receives the US FDA’s Approval for Acute Treatment of MigraineByRidhi RastogiMay 1, 20250Comments
News Amicus Therapeutics Enters a ~$590M Exclusive License Agreement with Dimerix for DMX-200ByRidhi RastogiMay 1, 20250Comments
SPOTLIGHT Reuters Pharma 2025: Post-Conference Talks Featuring Barbara AlbientzByHimanshu SehgalMay 1, 20250Comments
News Johnson & Johnson Reports the US FDA’s Approval of Imaavy (Nipocalimab-aahu) for Generalized Myasthenia Gravis (gMG)ByDipanshu DixitMay 1, 20250Comments
SPOTLIGHT Reuters Pharma 2025: Post-Conference Talks Featuring Michael BierlByHimanshu SehgalMay 1, 20250Comments
